Incysus Therapeutics to Present New Data at the American Association for Cancer Research (AACR) Annual Meeting 2019
March 19, 2019 07:00 ET
|
Incysus Therapeutics, Inc.
NEW YORK, March 19, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...